Cargando…

Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease

14-3-3 proteins are important negative regulators of cell death pathways. Recent studies have revealed alterations in 14-3-3s in Parkinson's disease (PD) and the ability of 14-3-3s to interact with α-synuclein (α-syn), a protein central to PD pathophysiology. In a transgenic α-syn mouse model,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yacoubian, T A, Slone, S R, Harrington, A J, Hamamichi, S, Schieltz, J M, Caldwell, K A, Caldwell, G A, Standaert, D G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998343/ https://www.ncbi.nlm.nih.gov/pubmed/21152247 http://dx.doi.org/10.1038/cddis.2009.4

Ejemplares similares

14-3-3theta Protects against Neurotoxicity in a Cellular Parkinson's Disease Model through Inhibition of the Apoptotic Factor Bax
por: Slone, Sunny R., et al.
Publicado: (2011)

Angiogenin in Parkinson Disease Models: Role of Akt Phosphorylation and Evaluation of AAV-Mediated Angiogenin Expression in MPTP Treated Mice
por: Steidinger, Trent U., et al.
Publicado: (2013)

Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins
por: Giusto, E., et al.
Publicado: (2021)

Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson’s disease models
por: Nourse, J. Brucker, et al.
Publicado: (2023)

14-3-3 phosphorylation inhibits 14-3-3θ’s ability to regulate LRRK2 kinase activity
por: Pattanayak, Rudradip, et al.
Publicado: (2023)

Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology
por: McFerrin, Michael B., et al.
Publicado: (2017)

Rapid Selection of Cyclic Peptides that Reduce α-Synuclein Toxicity in Yeast and Animal Models
por: Kritzer, Joshua A., et al.
Publicado: (2009)

Defects in Very Long Chain Fatty Acid Synthesis Enhance Alpha-Synuclein Toxicity in a Yeast Model of Parkinson's Disease
por: Lee, Yong Joo, et al.
Publicado: (2011)

Neuroprotective Function of 14-3-3 Proteins in Neurodegeneration
por: Shimada, Tadayuki, et al.
Publicado: (2013)

14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
por: Underwood, Rachel, et al.
Publicado: (2021)

Found in Translation: The Utility of C. elegans Alpha-Synuclein Models of Parkinson’s Disease
por: Gaeta, Anthony L., et al.
Publicado: (2019)

Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
por: Qiao, Liyan, et al.
Publicado: (2008)

Gene-by-environment interactions that disrupt mitochondrial homeostasis cause neurodegeneration in C. elegans Parkinson’s models
por: Kim, Hanna, et al.
Publicado: (2018)

Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model
por: Ray, A, et al.
Publicado: (2014)

Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress
por: Nourse, J. Brucker, et al.
Publicado: (2021)

14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer’s Disease Mouse Models
por: Gannon, Mary, et al.
Publicado: (2022)

An Environmental Contributor to Parkinson’s Disease Causes a Hormetic Lifespan Effect in C. elegans
por: Thies, Jennifer, et al.
Publicado: (2021)

An Environmental Contributor to Parkinson’s Disease Causes a Hormetic Lifespan Effect in C. elegans
por: Thies, Jennifer, et al.
Publicado: (2021)

No Country for Old Worms: A Systematic Review of the Application of C. elegans to Investigate a Bacterial Source of Environmental Neurotoxicity in Parkinson’s Disease
por: Caldwell, Kim A., et al.
Publicado: (2018)

Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson’s Disease
por: Wang, Shaoxiao, et al.
Publicado: (2016)

Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans
por: Gaeta, Anthony L., et al.
Publicado: (2022)

ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans
por: Griffin, Edward F., et al.
Publicado: (2019)

Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease
por: Carlisle, Samantha M., et al.
Publicado: (2021)

Vacuolar protein sorting protein 41 (VPS41) at an intersection of endosomal traffic in neurodegenerative disease
por: Griffin, Edward F., et al.
Publicado: (2019)

Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease
por: Yuan, Jiawen, et al.
Publicado: (2016)

Attenuation of Dopaminergic Neurodegeneration in a C. elegans Parkinson’s Model through Regulation of Xanthine Dehydrogenase (XDH-1) Expression by the RNA Editase, ADR-2
por: Starr, Lindsey A., et al.
Publicado: (2023)

Neuroprotective Effect of TAT-14-3-3ε Fusion Protein against Cerebral Ischemia/Reperfusion Injury in Rats
por: Zhu, Yuanjun, et al.
Publicado: (2014)

Retinal Neuroprotection From Optic Nerve Trauma by Deletion of Arginase 2
por: Xu, Zhimin, et al.
Publicado: (2018)

Mechanistic impacts of bacterial diet on dopaminergic neurodegeneration in a Caenorhabditis elegans α-synuclein model of Parkinson’s disease
por: Gaeta, Anthony L., et al.
Publicado: (2023)

Functional mapping of the 14-3-3 hub protein as a guide to design 14-3-3 molecular glues
por: Somsen, Bente A., et al.
Publicado: (2022)

Modeling neurodegeneration in Caenorhabditis elegans
por: Caldwell, Kim A., et al.
Publicado: (2020)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, α-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms
por: Tardiff, Daniel F., et al.
Publicado: (2012)

Circulating (Poly)phenol Metabolites: Neuroprotection in a 3D Cell Model of Parkinson's Disease
por: Carecho, Rafael, et al.
Publicado: (2022)

Neuroprotection by Nrf2 in Parkinson’s disease model
Publicado: (2011)

A Thermodynamic Model for Multivalency in 14-3-3 Protein–Protein Interactions
por: Stevers, Loes M., et al.
Publicado: (2018)

Modulators of 14-3-3 Protein–Protein Interactions
por: Stevers, Loes M., et al.
Publicado: (2017)

Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease
por: Thome, Aaron D., et al.
Publicado: (2015)

Human Brain-Based Models Provide a Powerful Tool for the Advancement of Parkinson’s Disease Research and Therapeutic Development
por: McComish, Sarah F., et al.
Publicado: (2022)

Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease
por: Schonhoff, A. M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j00abk3f41bnfpv8obke28int3